PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

Its been done before., page-2

  1. 5,261 Posts.
    lightbulb Created with Sketch. 145
    Results
    Hydrarthroses were reduced quickly in all cases. The clinical assessments, i.e., knee flexion, pain while walking, pain after climbing up and down stairs, etc, were improved significantly and these clinical improvements continued for almost one year. The dose used in thisstudy affected the blood coagulation test,but was within safe levels. Slightly abnormal findings were noted in serum triglycerides.

    Coagulation tests measure your blood’s ability to clot, and how long it takes to clot.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $101.4M
Open High Low Value Volume
29.0¢ 29.3¢ 28.0¢ $57.32K 198.9K

Buyers (Bids)

No. Vol. Price($)
1 12454 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 4443 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.